New radiation therapy shows promise for tough kidney cancer
NCT ID NCT06059014
First seen Apr 25, 2026 · Last updated May 15, 2026 · Updated 2 times
Summary
This early-phase study tested a new type of radiation therapy that targets a protein called PSMA on kidney cancer cells. Six adults with advanced clear cell kidney cancer that had spread and stopped responding to other treatments received four injections of the radioactive drug. The goal was to check safety and see if it could control the disease for at least 24 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CLEAR CELL RENAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Leon Berard
Lyon, 69008, France
Conditions
Explore the condition pages connected to this study.